These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2124641

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pericardiotomy improves left ventricular compliance during sepsis-induced pulmonary artery hypertension.
    Coons MS, Woloszyn TT, Folliguet TA, Rodriguez C, Levy R, Maughan R, Nathan IM, Marini CP.
    Am Surg; 1992 Jan; 58(1):32-6. PubMed ID: 1739227
    [Abstract] [Full Text] [Related]

  • 3. About mechanisms of prostaglandin E1 induced deterioration of pulmonary gas exchange in COPD patients.
    Dujić Z, Eterović D, Tocilj J, Kusić Z, Capkun V.
    Clin Physiol; 1993 Sep; 13(5):497-506. PubMed ID: 8222534
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of PGE1 in experimental vasoconstrictive pulmonary hypertension.
    Dagher E, Dumont L, Chartrand C, Blaise G.
    Eur Surg Res; 1993 Sep; 25(2):65-73. PubMed ID: 8482311
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
    Schmid ER, Bürki C, Engel MH, Schmidlin D, Tornic M, Seifert B.
    Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820
    [Abstract] [Full Text] [Related]

  • 8. Effects of lipo-prostaglandin E1 on pulmonary hemodynamics and clinical outcomes in patients with pulmonary arterial hypertension.
    Shen J, He B, Wang B.
    Chest; 2005 Aug; 128(2):714-9. PubMed ID: 16100159
    [Abstract] [Full Text] [Related]

  • 9. Role of prostaglandin E1 in reducing pulmonary vascular resistance in an experimental model of acute lung injury.
    Dervin G, Calvin JE.
    Crit Care Med; 1990 Oct; 18(10):1129-33. PubMed ID: 2209041
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension].
    Pan S, Xiao M, Liu Y.
    Zhonghua Wai Ke Za Zhi; 1996 May; 34(5):276-9. PubMed ID: 9387702
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiopulmonary effects of aerosolized prostaglandin E1 and nitric oxide inhalation in patients with acute respiratory distress syndrome.
    Putensen C, Hörmann C, Kleinsasser A, Putensen-Himmer G.
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1743-7. PubMed ID: 9620900
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hemodynamic effects of prostaglandin E1 in patients with congenital heart disease and pulmonary hypertension.
    Weesner KM.
    Cathet Cardiovasc Diagn; 1991 Sep; 24(1):10-5. PubMed ID: 1913785
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effects of different dosage of PGE1 in pulmonary arterial hypertension].
    Guo ZH, Ye YQ, Jing BW.
    Zhonghua Nei Ke Za Zhi; 1993 Sep; 32(9):591-3. PubMed ID: 8112140
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.